NCT01758315

Brief Summary

The purpose of the Proactive Reduction of Outpatient Malpractice: Increasing Safety, Efficiency, and Satisfaction (PROMISES) project is to assemble a high-level Massachusetts consortium to test the impact of powerful quality improvement techniques to accomplish innovations and improvements in high risk ambulatory malpractice areas. We will target problem-prone processes in 3 areas of identified risk: 1) medication management, 2) test ordering and results management 3) follow-up and referral management.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
213

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2010

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

December 3, 2012

Completed
29 days until next milestone

First Posted

Study publicly available on registry

January 1, 2013

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

January 1, 2013

Status Verified

December 1, 2012

Enrollment Period

2.9 years

First QC Date

December 3, 2012

Last Update Submit

December 24, 2012

Conditions

Keywords

AmbulatoryOutpatientMalpracticeQuality ImprovementPatient Safety

Outcome Measures

Primary Outcomes (1)

  • Staff and patient survey response distribution related to lab test result tracking, referral follow-up, medication management, and communication with patients and among practice staff

    Evidence of change in the distribution of staff and patient survey responses related to lab test result tracking, referral follow-up, medication management, and communication with patients and among practice staff

    Baseline and 15 months

Secondary Outcomes (3)

  • Number of abnormal lab or test results with improper clinical follow-up

    Baseline and 15 Months

  • Number of specialist referral recommendations with improper clinical follow-up

    Baseline and 15 Months

  • Number of contraindicated medication prescriptions

    Baseline and 15 Months

Study Arms (2)

Improvement Sessions

EXPERIMENTAL

We will implement a context-sensitive collaborative improvement model that will emphasize training and in-office coaching by quality improvement, efficiency and safety experts, as well as shared learning methods to develop, test and implement changes in the following four key risk areas: medication management; test and lab results management; follow-up and referral management; and communication - within and between practices as well as with patients.

Other: Training and in-office coaching

Control

NO INTERVENTION

Control practices will not receive training or in-office coaching.

Interventions

Participating practices will be coached to perform rapid, small-scale tests of change and to iteratively improve performance of problem-prone care systems, as well as to imbed simple measurement in routine daily work streams to guide improvement efforts. The sixteen intervention practices will serve as realistic research laboratories to help advance malpractice risk prevention and patient safety in specific areas by refining tools and strategies for smaller practices.

Improvement Sessions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary Subjects: staff members of small to medium-sized primary care (internal medicine or family medicine) practices in Massachusetts with adult, English-speaking patients.
  • Secondary Subjects: English-speaking adults who receive care at an enrolled intervention or control office practice.

You may not qualify if:

  • Non-English-speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Massachusetts Department of Public Health

Boston, Massachusetts, 02111, United States

Location

Brigham and Women's Hospital

Boston, Massachusetts, 02120, United States

Location

Study Officials

  • Madeleine Biondolillo, MD

    Massachusetts Department of Health

    PRINCIPAL INVESTIGATOR
  • Gordon Schiff, MD

    Brigham and Women's Hospital

    STUDY CHAIR
  • Nicholas Leydon, MPH

    Massachusetts Department of Health

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Bureau of Health Care Safety and Quality

Study Record Dates

First Submitted

December 3, 2012

First Posted

January 1, 2013

Study Start

July 1, 2010

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

January 1, 2013

Record last verified: 2012-12

Locations